Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
PMID: 39707077
Source: Clin Pharmacokinet
Publication date:
2025-07-24
Year:
2025
Abstract
NULL